Clinical pharmacology of cyclophosphamide.
D000478:Alkylation; D000493:Allopurinol / Q000494:pharmacology / Q000627:therapeutic use; D001798:Blood Proteins; D002247:Carbon Isotopes; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use / Q000652:urine; D005243:Feces / Q000032:analysis; D006207:Half-Life; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism; D008113:Liver Neoplasms / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy*; D009578:Nitrobenzenes; D011239:Prednisolone / Q000494:pharmacology / Q000627:therapeutic use; D011485:Protein Binding; D011725:Pyridines; D013997:Time Factors; D014462:Ultrafiltration
D001798:Blood Proteins; D002247:Carbon Isotopes; D009578:Nitrobenzenes; D011725:Pyridines; D000493:Allopurinol; D003520:Cyclophosphamide; D011239:Prednisolone